Laird Harrison
Drug, device innovations making strides for glaucoma care in 2017
Glaucoma innovations in 2017 included advancements in new drugs, new microinvasive glaucoma surgery devices, and a new diagnostic tool. Two glaucoma specialists review some of the year’s highlights.
Screening guide: Shared decision-making’s role
Years ago, decisions about screening men for PSA looked relatively straightforward. You offered screening to patients aged 40 or older, performed a biopsy on the ones with a total PSA >4.0 ng/mL, and offered treatment to those with positive biopsies. Today, conflicting guidelines and new techniques in cancer detection and treatment have left clinicians with a more complicated puzzle. The good news, experts say, is that physicians who put these pieces together stand a better chance of protecting their patients’ health than ever before.
Acrylic conformers effective in congenital anophthalmia
Acrylic expanders may be an option for the management of patients with congenital anophthalmos and microphthalmos.
2015 brings big Medicare changes, small technology changes to glaucoma surgery
The year 2015 brought a trickle of innovation to the technique of glaucoma surgery, and a tidal wave of change to the business model in the United States.
Some Insurers Still Reluctant to Pay for New Biologic Drugs
Maui, Hawaii - Some insurers are reluctant to pay for the new biologic drugs for psoriasis, despite the approval of two of the drugs by the U.S. Food and Drug Administration, according to William Abramovits, M.D.
Some skin conditions more prevalent in East Indian patients
San Diego - Lichen planus pigmentosus, melasma and cutaneous tuberculosis are among the diseases facing U.S. dermatologists in larger numbers as a result of immigration from the Indian subcontinent, according to Lalit K. Bhutani, M.D., a senior consultant in dermatology at the Sitaram Bhartia Institute of Science and Research in New Delhi.
Ancient 'cure' finds believers in the 'burbs
Maui, Hawaii - For thousands of years, people have flocked to the Dead Sea searching for relief for their itchy skin. Now, Chicago-area psoriasis and atopic dermatitis sufferers are bathing in reconstituted Dead Sea water at a suburban clinic.
Dosing strategies
Washington - The optimum doses of biologic treatments for psoriasis may be higher than previously believed, according to Mark Lebwohl, M.D., professor and chairman, department of dermatology, Mt. Sinai School of Medicine.
Natural forces?
Waikoloa, Hawaii - Controlled studies show water from thermal springs in Avene, France, reduces inflammation, pruritis, and erythema, according to a general practitioner whose employer markets the water. The water is effective in treating psoriasis, inflammation caused by laser treatments, and mild to moderate atopic dermatitis, said Fran?ois Verriere, M.D., at the Hawaii Dermatology Seminar.
Biologic lifelines
Washington - Five new biologic drugs for psoriasis offer useful alternatives when the standard therapies cannot be used, according to Henry W. Lim, M.D. Dr. Lim focused on the five biologics in his summary of the most important recent developments in medical dermatology for the American Academy of Dermatology annual meeting.

Poll

View Results